{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:51:41Z","timestamp":1793040701697,"version":"4.5.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":140,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["ME200246"],"award-info":[{"award-number":["ME200246"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL168588"],"award-info":[{"award-number":["R01HL168588"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of War","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA279962"],"award-info":[{"award-number":["R01CA279962"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["24TPA1303687"],"award-info":[{"award-number":["24TPA1303687"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jconrel.2026.114720","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:55:16Z","timestamp":1770882916000},"page":"114720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Microbial medicines: Unlocking the therapeutic potential of the microbiome in cancer treatment"],"prefix":"10.1016","volume":"392","author":[{"given":"Abram","family":"Canowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin S.","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Muck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komalpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Bellala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh Babulal","family":"Gabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalinikanth","family":"Kotagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40487-021-00177-x","article-title":"Bacterial-based methods for cancer treatment: What we know and where we are","volume":"10","author":"Rommasi","year":"2022","journal-title":"Oncol. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114720_bb0010","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s44319-025-00386-9","article-title":"Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite","volume":"26","author":"Vaaben","year":"2025","journal-title":"EMBO Rep."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114720_bb0015","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144880","article-title":"Leveraging copper import by yersiniabactin siderophore system for targeted PET imaging of bacteria","volume":"6","author":"Siddiqui","year":"2021","journal-title":"JCI Insight"},{"issue":"29","key":"10.1016\/j.jconrel.2026.114720_bb0020","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114720_bb0025","first-page":"1","article-title":"Engineered bacteria enhance immunotherapy and targeted therapy through stromal remodeling of tumors","volume":"11","author":"Thomas","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114720_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.202202870","article-title":"An engineered probiotic platform for cancer epitope-independent targeted radionuclide therapy of solid tumors","volume":"12","author":"Siddiqui","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"530","key":"10.1016\/j.jconrel.2026.114720_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"17","key":"10.1016\/j.jconrel.2026.114720_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsle\/fny180","article-title":"Characterisation and pure culture of putative health-associated oral bacterium BU063 (Tannerella sp. HOT-286) reveals presence of a potentially novel glycosylated S-layer","volume":"365","author":"Frey","year":"2018","journal-title":"FEMS Microbiol. Lett."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114720_bb0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.embor.7400731","article-title":"The gut flora as a forgotten organ","volume":"7","author":"O\u2019Hara","year":"2006","journal-title":"EMBO Rep."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114720_bb0050","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1136\/gutjnl-2024-332815","article-title":"Stomach microbiota in gastric cancer development and clinical implications","volume":"73","author":"Zeng","year":"2024","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1909459","article-title":"The interplay between Helicobacter pylori and gastrointestinal microbiota","volume":"13","author":"Chen","year":"2021","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114720_bb0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.smim.2007.04.002","article-title":"Paneth cells, defensins, and the commensal microbiota: A hypothesis on intimate interplay at the intestinal mucosa","volume":"19","author":"Salzman","year":"2007","journal-title":"Semin. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114720_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tim.2022.08.010","article-title":"Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer","volume":"31","author":"Wang","year":"2023","journal-title":"Trends Microbiol."},{"issue":"June","key":"10.1016\/j.jconrel.2026.114720_bb0070","first-page":"1","article-title":"The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-024-01821-0","article-title":"Microbial signatures and continuum in endometrial cancer and benign patients","volume":"12","author":"Semertzidou","year":"2024","journal-title":"Microbiome"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114720_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-019-0297-0","article-title":"Bacteria-cancer interactions: bacteria-based cancer therapy","volume":"51","author":"Duong","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114720_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011281","article-title":"Unlocking the power of the microbiome for successful cancer immunotherapy","volume":"13","author":"Clavijo-Salomon","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"June","key":"10.1016\/j.jconrel.2026.114720_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41579-024-01141-y","article-title":"Microbial secondary metabolites: advancements to accelerate discovery towards application","volume":"23","author":"Dinglasan","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114720_bb0095","series-title":"\u201cUtilization of the microbiome in personalized medicine,\u201d vol. 22, no. May","author":"Ratiner","year":"2024"},{"issue":"April","key":"10.1016\/j.jconrel.2026.114720_bb0100","article-title":"The gut microbiome and dietary fibres: implications in obesity, cardiometabolic diseases and cancer","volume":"23","author":"Delzenne","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"issue":"October","key":"10.1016\/j.jconrel.2026.114720_bb0105","article-title":"Gut microbiota-derived short-chain fatty acids and their role in human health and disease","volume":"23","author":"Mukhopadhya","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114720_bb0110","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s12276-020-00499-2","article-title":"Single-cell sequencing techniques from individual to multiomics analyses","volume":"52","author":"Kashima","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.114720_bb0115","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-019-1058-4","article-title":"Engineering the flagellar type III secretion system: improving capacity for secretion of recombinant protein","author":"Green","year":"2019","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.jconrel.2026.114720_bb0120","series-title":"Bioengineering of Escherichia coli Flagellar Type III Secretion system (fTTSS) for the maximal efficiency of protein production","author":"Kamble","year":"2018"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114720_bb0125","article-title":"Characterization of lung and oral microbiomes in lung cancer","volume":"11","author":"Sun","year":"2023","journal-title":"Am. Soc. Microbiol."},{"issue":"6695","key":"10.1016\/j.jconrel.2026.114720_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj4857","article-title":"A blueprint for tumor-infiltrating B cells across human cancers","volume":"384","author":"Ma","year":"2024","journal-title":"Science (80-.)"},{"issue":"7937","key":"10.1016\/j.jconrel.2026.114720_bb0135","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Ni\u00f1o","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2025.104341","volume":"7","author":"Kamble","year":"2026","journal-title":"STAR Protoc."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114720_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics13060502","article-title":"Implications of artificial intelligence in addressing antimicrobial resistance: innovations, global challenges, and healthcare\u2019s future","volume":"13","author":"Branda","year":"2024","journal-title":"Antibiotics"},{"issue":"March","key":"10.1016\/j.jconrel.2026.114720_bb0150","article-title":"Progressing microbial genomics: Artificial intelligence and deep learning driven advances in genome analysis and therapeutics","volume":"11","author":"Dhaarani","year":"2025","journal-title":"Intell. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114720_bb0155","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.ygeno.2020.03.020","article-title":"Molib: A machine learning based classification tool for the prediction of biofilm inhibitory molecules","volume":"112","author":"Srivastava","year":"2020","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-022-05061-7","article-title":"MP4: a machine learning based classification tool for prediction and functional annotation of pathogenic proteins from metagenomic and genomic datasets","volume":"23","author":"Gupta","year":"2022","journal-title":"BMC Bioinformatics"},{"issue":"OCT","key":"10.1016\/j.jconrel.2026.114720_bb0165","first-page":"1","article-title":"The antitumor activity of combinations of cytotoxic chemotherapy and immune checkpoint inhibitors is model-dependent","volume":"9","author":"Grasselly","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114720_bb0170","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/cam4.2148","article-title":"Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities","volume":"8","author":"Sedighi","year":"2019","journal-title":"Cancer Med."},{"issue":"January","key":"10.1016\/j.jconrel.2026.114720_bb0175","first-page":"1","article-title":"Nanobodies in cell-mediated immunotherapy: On the road to fight cancer","volume":"14","author":"Maali","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114720_bb0180","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"6536","key":"10.1016\/j.jconrel.2026.114720_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science (80-.)"},{"issue":"7614","key":"10.1016\/j.jconrel.2026.114720_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12934-019-1058-4","article-title":"Engineering the flagellar type III secretion system: improving capacity for secretion of recombinant protein","volume":"18","author":"Green","year":"2019","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.jconrel.2026.114720_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02786-w","article-title":"Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy","author":"Ijaz","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0205","first-page":"1","article-title":"Hypoxia signaling in human health and diseases: implications and prospects for therapeutics","volume":"7","author":"Luo","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"15","key":"10.1016\/j.jconrel.2026.114720_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202105086","article-title":"Bacteria-elicited specific thrombosis utilizing acid-induced cytolysin a expression to enable potent tumor therapy","volume":"9","author":"Qin","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114720_bb0215","series-title":"Bacterial Drug Delivery Systems for Cancer Therapy: \u2018Why\u2019 and \u2018How,\u2019","author":"Zhao","year":"2023"},{"key":"10.1016\/j.jconrel.2026.114720_bb0220","series-title":"\u201cHarnessing the Therapeutic Potential of Extracellular Vesicles for Biomedical Applications using Multifunctional Magnetic Nanomaterials,\u201d vol. 18, no. 13","first-page":"1","author":"Rathnam","year":"2023"},{"issue":"249","key":"10.1016\/j.jconrel.2026.114720_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008982","article-title":"Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses","volume":"6","author":"Roberts","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114720_bb0230","first-page":"473","article-title":"Localization of the vegetative form of clostridium tetani in mouse tumors following intravenous spore administration","volume":"15","author":"Malmgren","year":"1955","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114720_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mco2.417","article-title":"Microbiota in cancer: molecular mechanisms and therapeutic interventions","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm"},{"issue":"November","key":"10.1016\/j.jconrel.2026.114720_bb0240","first-page":"1","article-title":"The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114720_bb0245","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.chom.2025.04.008","article-title":"Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPK","volume":"33","author":"Huang","year":"2025","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2026.114720_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2389523","article-title":"Targeting oxidatively induced DNA damage response in cancer: Opportunities for novel cancer therapies","volume":"2018","author":"Davalli","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00916-z","article-title":"CGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114720_bb0260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/9781555819705.ch14","article-title":"Engineering diagnostic and therapeutic gut bacteria","author":"Landry","year":"2018","journal-title":"Bugs as Drugs Ther. Microbes Prev. Treat. Dis."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114720_bb0265","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","article-title":"Exploiting bacteria for cancer immunotherapy","volume":"21","author":"Kwon","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"November","key":"10.1016\/j.jconrel.2026.114720_bb0270","first-page":"1","article-title":"Novel strategies for efficient production and delivery of live biotherapeutics and biotechnological uses of lactococcus lactis: the lactic acid bacterium model","volume":"8","author":"Tavares","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"18","key":"10.1016\/j.jconrel.2026.114720_bb0275","doi-asserted-by":"crossref","first-page":"8759","DOI":"10.1039\/D3NR06666E","article-title":"Breaking barriers in cancer treatment: nanobiohybrids empowered by modified bacteria and vesicles","volume":"16","author":"Ijaz","year":"2024","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114720_bb0280","article-title":"CRISPR-Cas9 delivery strategies and applications: review and update","volume":"62","author":"Severi","year":"2024","journal-title":"Genes. (United States)"},{"issue":"6658","key":"10.1016\/j.jconrel.2026.114720_bb0285","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.adf3974","article-title":"Engineered bacteria detect tumor DNA","volume":"381","author":"Cooper","year":"2023","journal-title":"Science (80-.)"},{"issue":"6667","key":"10.1016\/j.jconrel.2026.114720_bb0290","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.add7034","article-title":"Probiotic-guided CAR-T cells for solid tumor targeting","volume":"382","author":"Vincent","year":"2023","journal-title":"Science (80-. )"},{"key":"10.1016\/j.jconrel.2026.114720_bb0295","series-title":"\u201cLipid Droplet \u2013 enriched Luminogens enable Adoptive Macrophage Transfer for Treatment of Bacterial Sepsis,\u201d vol. 8376, no. June","first-page":"1","author":"Liu","year":"2025"},{"key":"10.1016\/j.jconrel.2026.114720_bb0300","series-title":"Advances in Engineered Phages for Disease Treatment","first-page":"1","volume":"2401611","author":"Hou","year":"2025"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114720_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052056","article-title":"Living bacteria: a new vehicle for vaccine delivery in cancer immunotherapy","volume":"26","author":"Yang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6622","key":"10.1016\/j.jconrel.2026.114720_bb0310","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.add9667","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"2022","journal-title":"Science (80-.)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0315","first-page":"1","article-title":"2011, NATURE, Robust multicellular computing using genetically encoded NOR gates and chemical \u2018wires,\u2019","volume":"23","author":"Lin","year":"2014","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41522-024-00479-8","article-title":"Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer","volume":"10","author":"Zhou","year":"2024","journal-title":"npj Biofilms Microbiomes"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-37950-7","article-title":"Quorum sensing as a mechanism to harness the wisdom of the crowds","volume":"14","author":"Moreno-G\u00e1mez","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114720_bb0330","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1073\/pnas.1414558112","article-title":"Quorum-sensing Salmonella selectively trigger protein expression within tumors","volume":"112","author":"Swofford","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0335","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17475-z","article-title":"Majority sensing in synthetic microbial consortia","volume":"11","author":"Alnahhas","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114720_bb0340","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.celrep.2020.02.033","article-title":"Synthetic cassettes for pH-mediated sensing, counting, and containment","volume":"30","author":"Stirling","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29065-2","article-title":"Ultrasound-controllable engineered bacteria for cancer immunotherapy","volume":"13","author":"Abedi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114720_bb0350","series-title":"Source: Washington University submitted to NRP Development of Kill-switches for Biocontainment of Genetically Engineered","author":"Drive","year":"2020"},{"issue":"March","key":"10.1016\/j.jconrel.2026.114720_bb0355","first-page":"1","article-title":"pH-Responsive Polymer Nanomaterials for Tumor Therapy","volume":"12","author":"Chu","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-53546-1","article-title":"Optogenetic patterning generates multi-strain biofilms with spatially distributed antibiotic resistance","volume":"15","author":"Jin","year":"2024","journal-title":"Nat. Commun."},{"issue":"March","key":"10.1016\/j.jconrel.2026.114720_bb0365","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2023.06.009","article-title":"Cancer phototherapy with nano-bacteria biohybrids","volume":"360","author":"Lu","year":"2023","journal-title":"J. Control. Release"},{"issue":"January","key":"10.1016\/j.jconrel.2026.114720_bb0370","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jconrel.2021.05.004","article-title":"Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy","volume":"334","author":"Panikar","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0375","first-page":"1","article-title":"Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy","volume":"9","author":"Xiao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"49","key":"10.1016\/j.jconrel.2026.114720_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adma.202206765","article-title":"Dual-cascade responsive nanoparticles enhance pancreatic cancer therapy by eliminating tumor-resident intracellular bacteria","volume":"34","author":"Kang","year":"2022","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114720_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040784","article-title":"Bacteria as nanoparticle carriers for immunotherapy in oncology","volume":"14","author":"Moreno","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114720_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14081566","article-title":"Nanocarriers: a reliable tool for the delivery of anticancer drugs","volume":"14","author":"Sabit","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114720_bb0395","first-page":"1","article-title":"Immune Checkpoint Inhibitors","author":"Kalinski","year":"2019","journal-title":"Immune Checkp. Inhib. Cancer"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114720_bb0400","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","article-title":"Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer","volume":"187","author":"Jia","year":"2024","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114720_bb0405","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","article-title":"Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer","volume":"31","author":"Jiang","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2026.114720_bb0410","series-title":"A new discovery could lead to immunotherapy that turns \u2018 cold tumors \u2019 into \u2018 hot tumors \u2019","author":"Us","year":"2022"},{"issue":"13","key":"10.1016\/j.jconrel.2026.114720_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.adt7298","article-title":"Programmable engineered bacteria as sustained-releasing antibody factory in situ for enhancing tumor immune checkpoint therapy","volume":"11","author":"Xie","year":"2025","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114720_bb0420","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-024-03665-x","article-title":"Bifidobacterium modulation of tumor immunotherapy and its mechanism","volume":"73","author":"Pei","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.114720_bb0425","series-title":"Engineered gold nanoparticles for photothermal cancer therapy and bacteria killing, vol. 6, no. 112","author":"Gharatape","year":"2016"},{"issue":"15","key":"10.1016\/j.jconrel.2026.114720_bb0430","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.7150\/thno.98257","article-title":"Enhancing photothermal therapy of tumors with image-guided thermal control of gene-expressing bacteria","volume":"14","author":"Zeng","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01373-1","article-title":"Bacteria-driven hypoxia targeting delivery of chemotherapeutic drug proving outcome of breast cancer","volume":"20","author":"Xiao","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114720_bb0440","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"January","key":"10.1016\/j.jconrel.2026.114720_bb0445","article-title":"Immunotherapy-based combinations in metastatic NSCLC","volume":"116","author":"Desai","year":"2023","journal-title":"Cancer Treat. Rev."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114720_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11071652","article-title":"Recent advances in the use of probiotics to improve meat quality of small ruminants: a review","volume":"11","author":"Saha","year":"2023","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114720_bb0455","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1016\/j.apsb.2022.10.013","article-title":"The role of bacteria and its derived biomaterials in cancer radiotherapy","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114720_bb0460","first-page":"755","article-title":"Colorectal cancer therapy using a pediococcus pentosaceus SL4 drug delivery system secreting lactic acid bacteria-derived protein p8","volume":"42","author":"An","year":"2019","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114720_bb0465","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/acssynbio.1c00452","article-title":"Precise thermal regulation of engineered bacteria secretion for breast cancer treatment in Vivo","volume":"11","author":"Li","year":"2022","journal-title":"ACS Synth. Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-26105-1","article-title":"Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer","volume":"12","author":"Deb","year":"2022","journal-title":"Sci. Rep."},{"issue":"40","key":"10.1016\/j.jconrel.2026.114720_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adma.202206200","article-title":"Engineered bacterial outer membrane vesicles as controllable two-way adaptors to activate macrophage phagocytosis for improved tumor immunotherapy","volume":"34","author":"Feng","year":"2022","journal-title":"Adv. Mater."},{"issue":"December 2021","key":"10.1016\/j.jconrel.2026.114720_bb0480","doi-asserted-by":"crossref","first-page":"135566","DOI":"10.1016\/j.cej.2022.135566","article-title":"Anaerobic bacteria mediated \u2018smart missile\u2019 targeting tumor hypoxic area enhances the therapeutic outcome of lung cancer","volume":"438","author":"Li","year":"2022","journal-title":"Chem. Eng. J."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114720_bb0485","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adc9436","article-title":"Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity","volume":"9","author":"Savage","year":"2023","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114720_bb0490","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.apsb.2022.09.016","article-title":"Salmonella-mediated blood\u2013brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo\/bacterial glioma therapy","volume":"13","author":"Mi","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"6641","key":"10.1016\/j.jconrel.2026.114720_bb0495","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.abp9563","article-title":"Engineered skin bacteria induce antitumor T cell responses against melanoma","volume":"380","author":"Chen","year":"2023","journal-title":"Science (80-.)"},{"key":"10.1016\/j.jconrel.2026.114720_bb0500","article-title":"A bacterial living therapeutics with engineered protein secretion circuits to eliminate breast cancer cells","author":"Shahid","year":"2023","journal-title":"bioRxiv"},{"issue":"March","key":"10.1016\/j.jconrel.2026.114720_bb0505","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2147\/IJN.S396863","article-title":"Bacteria-driven tumor microenvironment-sensitive nanoparticles targeting hypoxic regions enhances the chemotherapy outcome of lung cancer","volume":"18","author":"Shi","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"42","key":"10.1016\/j.jconrel.2026.114720_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adfm.202303254","article-title":"Bioactive bacteria\/MOF hybrids can achieve targeted synergistic chemotherapy and chemodynamic therapy against breast tumors","volume":"33","author":"Li","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"14","key":"10.1016\/j.jconrel.2026.114720_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202308242","article-title":"BCG as an innovative option for HCC treatment: repurposing and mechanistic insights","volume":"11","author":"Vaziri","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0520","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-44776-4","article-title":"Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia","volume":"15","author":"Gurbatri","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114720_bb0525","series-title":"\u201cMicrobial Therapeutics in Oncology: A Comprehensive Review of Bacterial Role in Cancer Treatment,\u201d vol. 16, no. 10","author":"Kunjalwar","year":"2024"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114720_bb0530","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4251\/wjgo.v15.i5.713","article-title":"Intratumour microbiome of pancreatic cancer","volume":"15","author":"Guan","year":"2023","journal-title":"World J. Gastrointest. Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114720_bb0535","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ymthe.2021.08.023","article-title":"Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimurium","volume":"30","author":"Tan","year":"2022","journal-title":"Mol. Ther."},{"issue":"14","key":"10.1016\/j.jconrel.2026.114720_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143565","article-title":"Collagenase-expressing salmonella targets major collagens in pancreatic cancer leading to reductions in immunosuppressive subsets and tumor growth","volume":"13","author":"Ebelt","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114720_bb0545","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1158\/1535-7163.MCT-19-0556","article-title":"Hyaluronidase-expressing Salmonella effectively targets tumor-associated hyaluronic acid in pancreatic ductal adenocarcinoma","volume":"19","author":"Ebelt","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2026.114720_bb0550","series-title":"\u201cA Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer Overview,\u201d no. Part 1","first-page":"1","author":"Garfield","year":"2023"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0555","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2500056","article-title":"Engineered bacteria as an orally administered anti-viral treatment and immunization system","volume":"17","author":"Kamble","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jconrel.2026.114720_bb0560","series-title":"\u201cBacteria-Based Nanoprobes for Cancer Therapy,\u201d no. January","author":"Lu","year":"2024"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0565","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2236364","article-title":"Colorectal cancer and gut microbiota studies in China","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0570","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2185028","article-title":"Intestinal bacteria and colorectal cancer: etiology and treatment","volume":"15","author":"Dougherty","year":"2023","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114720_bb0575","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijrobp.2022.07.352","article-title":"Radiolytic escherichia coli nissle: a novel radiosensitizer delivery platform using a live bacterial therapeutic","volume":"114","author":"Kamble","year":"2022","journal-title":"Int. J. Radiat. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114720_bb0580","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/cam4.2148","article-title":"Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities","volume":"8","author":"Xiao","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.jconrel.2026.114720_bb0585","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jenvrad.2017.09.013","article-title":"Radiation, radionuclides and bacteria: An in-perspective review","volume":"180","author":"Shukla","year":"2017","journal-title":"J. Environ. Radioact."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0590","article-title":"Current understanding of the intratumoral microbiome in various tumors","volume":"4","author":"Xue","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114720_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsyr\/foz007","article-title":"Yeast-based vaccines: New perspective in vaccine development and application","volume":"19","author":"Kumar","year":"2019","journal-title":"FEMS Yeast Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0600","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1086\/426454","article-title":"The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins","volume":"191","author":"Bobbins","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"13","key":"10.1016\/j.jconrel.2026.114720_bb0605","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I study of SYNB1891, an engineered E. coli nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"8_Supplement","key":"10.1016\/j.jconrel.2026.114720_bb0610","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2023-CT035","article-title":"Abstract CT035: Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival","volume":"83","author":"Kavan","year":"2023","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114720_bb0615","first-page":"139","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access","volume":"176","author":"Chirag","year":"2019","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0620","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","article-title":"Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma","volume":"20","author":"Toso","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114720_bb0625","article-title":"Center for biologics evaluation and research","author":"Resources","year":"2020","journal-title":"Definitions"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0630","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat. Commun."},{"issue":"June","key":"10.1016\/j.jconrel.2026.114720_bb0635","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.omtm.2021.04.001","article-title":"Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs","volume":"21","author":"Drago","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2026.114720_bb0640","doi-asserted-by":"crossref","DOI":"10.18231\/978-93-91208-94-3","article-title":"Pharmaceutical microbiology","author":"Tyagi","year":"2023","journal-title":"Pharm. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0645","first-page":"1","article-title":"\u57fa\u56e0\u7684\u6539\u53d8NIH Public Access","volume":"23","author":"Nguyen","year":"2011","journal-title":"Science (80-.)"},{"key":"10.1016\/j.jconrel.2026.114720_bb0650","series-title":"Regenerative Medicine Advanced Therapy Designation | FDA","author":"FDA","year":"2023"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0655","first-page":"1","article-title":"Challenges and solutions for the downstream purification of therapeutic proteins","volume":"7","author":"Tang","year":"2024","journal-title":"Antib. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114720_bb0660","doi-asserted-by":"crossref","first-page":"97","DOI":"10.38212\/2224-6614.3540","article-title":"Regulatory framework and challenges for live biotherapeutic products in Taiwan","volume":"33","author":"Pan","year":"2025","journal-title":"J. Food Drug Anal."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114720_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-015-0272-y","article-title":"Scale-up bioprocess development for production of the antibiotic valinomycin in Escherichia coli based on consistent fed-batch cultivations","volume":"14","author":"Li","year":"2015","journal-title":"Microb. Cell Factories"},{"issue":"February","key":"10.1016\/j.jconrel.2026.114720_bb0670","first-page":"1","article-title":"Biocontainment strategies for in vivo applications of Saccharomyces boulardii","volume":"11","author":"Hedin","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114720_bb0675","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40259-018-0300-7","article-title":"Ensuring product quality, consistency and patient supply over time for a large-volume biologic: experience with Remicade\u00ae","volume":"32","author":"Melsheimer","year":"2018","journal-title":"BioDrugs"},{"issue":"June","key":"10.1016\/j.jconrel.2026.114720_bb0680","article-title":"Good Manufacturing Practice (GMP) compliance for phage therapy medicinal products","volume":"11","author":"Bretaudeau","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114720_bb0685","series-title":"Report License Selection","author":"Analysis","year":"2025"},{"key":"10.1016\/j.jconrel.2026.114720_bb0690","series-title":"Live Biotherapeutic Products And Microbiome CDMO Market Summary","author":"Products","year":"2025"},{"key":"10.1016\/j.jconrel.2026.114720_bb0695","series-title":"Live Biotherapeutics Market Outlook 2034: Accelerating at 14 % CAGR , Projected to Reach US $ 422 . 9 Million , Latest Report by TMR","year":"2025"},{"key":"10.1016\/j.jconrel.2026.114720_bb0700","series-title":"Biologics Strategic Research Report 2024- 2030: Global Market to Reach $ 732. 4 Billion - Collaborations and Partnerships Fueling Developments and Commercialization","author":"Cookies","year":"2025"},{"issue":"21","key":"10.1016\/j.jconrel.2026.114720_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202200470","article-title":"Microbiota in tumors: from understanding to application","volume":"9","author":"Xie","year":"2022","journal-title":"Adv. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:49:08Z","timestamp":1787255348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":141,"alternative-id":["S0168365926001227"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114720","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbial medicines: Unlocking the therapeutic potential of the microbiome in cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114720"}}